WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul A. MahonEVP GENERAL COUNSEL2025-06-262,334$287.21
$670.35kSell
Paul A. MahonEVP GENERAL COUNSEL2025-06-262,537$284.10
$720.77kSell
Paul A. MahonEVP GENERAL COUNSEL2025-06-263,940$285.01
$1.12MSell
Paul A. MahonEVP GENERAL COUNSEL2025-06-26939$286.13
$268.68kSell
Paul A. MahonEVP GENERAL COUNSEL2025-06-2611,000$135.42
$1.49MBuy
Paul A. MahonEVP GENERAL COUNSEL2025-06-26100$288.80
$28.88kSell
Paul A. MahonEVP GENERAL COUNSEL2025-06-261,150$287.92
$331.11kSell
Nilda MesaDirector2025-06-24645$289.99
$187.05kSell
Richard GiltnerDirector2025-06-243,036$289.60
$879.21kSell
Richard GiltnerDirector2025-06-245,000$175.43
$877.15kBuy

1 of 87

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.07%5,446,092$1.60BInstitution
Lilly Co Eli11.64%5,251,394$1.55BInsider
Vanguard Group Inc9.88%4,457,135$1.31BInstitution
Avoro Capital Advisors LLC5.93%2,675,000$787.76MInstitution
State Street Corp4.95%2,230,708$656.92MInstitution
Renaissance Technologies LLC4.67%2,106,992$620.49MInstitution
Wellington Management Group LLP4.49%2,026,416$596.76MInstitution
Geode Capital Management LLC2.71%1,223,993$360.45MInstitution
Fmr LLC2.54%1,144,603$337.07MInstitution
Aqr Capital Management LLC2.01%908,448$267.53MInstitution

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR87.49%12.51%Net SellingNet Buying
INCY76.69%23.31%Net SellingNet Selling
GMAB98.03%0.00%
EXEL92.11%5.25%Net SellingNet Selling
MRNA72.07%22.78%Net BuyingNet Selling
View Top Biotech Stocks

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 97.65% institutional shareholders, 13.96% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 11.64% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $1.55B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.